Skip to main content
logo
Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
11,960
0.00 (0.00%)
Sep 17, 2026, 5:28 PM IDT

TLV:TEVA Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
17,31517,25816,54415,84614,92515,878
Revenue Growth
4.13%4.32%4.41%6.17%-6.00%-4.69%
Gross Profit
9,0838,9388,0637,6466,9737,594
Operating Income
3,2803,9523,3733,1852,6623,079
Net Income
7061,410-1,639-559-2,446417
Earnings Per Share
0.601.21-1.45-0.50-2.200.38
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Europe
5,1515,0405,1034,8374,5254,886
Other Activities
9058709449261,0451,151
International Markets
2,1592,1622,4632,3512,3522,032
UNITED STATES
9,1009,1868,0347,7317,003-
Total
17,31517,25816,54415,84514,92515,878

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,6553,5563,3003,2262,8012,165
Total Debt
16,89417,23018,18420,27321,67623,593
Net Cash (Debt)
-13,239-13,674-14,884-17,047-18,875-21,428
Net Cash Growth
------
Net Cash Per Share
-11.38-11.76-13.16-15.23-17.00-19.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,8981,6491,2471,3681,590798
Capital Expenditures
-551-501-498-526-548-562
Free Cash Flow
1,3471,1487498421,042236
Free Cash Flow Growth
51.35%53.27%-11.04%-19.19%341.52%-63.01%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
52.46%51.79%48.74%48.25%46.72%47.83%
Operating Margin
18.94%22.90%20.39%20.10%17.84%19.39%
Pretax Margin
4.15%7.17%-7.76%-3.93%-21.05%4.20%
Profit Margin
4.08%8.17%-9.91%-3.53%-16.39%2.63%
FCF Margin
7.78%6.65%4.53%5.31%6.98%1.49%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
65.8125.40---21.19
P/FCF Ratio
34.4931.1933.3913.909.7237.44
PS Ratio
2.682.081.510.740.680.56